Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group
(Q70218321)
scientific article published on 01 July 1991
scientific article published on 01 July 1991
Language:
other details
description | scientific article published on 01 July 1991 |
External Links
(P356) |
10.1016/S0272-6386(12)80290-3
|
(P698) |
2063855
|